Pharmacokinetic and other drug interactions in patients with AIDS

被引:38
作者
Dasgupta, A
Okhuysen, PC
机构
[1] Univ Texas, Houston Med Sch, Dept Pathol & Lab Med, Houston, TX 77030 USA
[2] Univ Texas, Houston Med Sch, Div Infect Dis, Houston, TX 77030 USA
关键词
AIDS; drug interactions; drug monitoring;
D O I
10.1097/00007691-200112000-00001
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
A variety of medications are used in treating patients infected with the human immunodeficiency virus (HIV). These medications are used to control viremia and to prevent and treat opportunistic infections. An individual is often required to take numerous drugs at the same time and thus clinicians are confronted with potential drug interactions, some of which are significant. Three different groups of anti-HIV drugs are used to treat patients. These groups include nucleoside reverse transcription inhibitors, non-nucleoside reverse transcription inhibitors, and protease inhibitors. This article reviews the most relevant drug interactions that occur during the treatment of HIV-infected patients with traditional and also alternative drugs. The role of therapeutic drug monitoring in the routine management of HIV-infected patients is discussed.
引用
收藏
页码:591 / 605
页数:15
相关论文
共 110 条
[11]  
BURGER DM, 1998, AIDS S, V12, pS461
[12]   Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease [J].
Cameron, DW ;
Heath-Chiozzi, M ;
Danner, S ;
Cohen, C ;
Kravcik, S ;
Maurath, C ;
Sun, E ;
Henry, D ;
Rode, R ;
Potthoff, A ;
Leonard, J .
LANCET, 1998, 351 (9102) :543-549
[13]   Antiretroviral therapy for HIV infection in 1998 - Updated recommendations of the International AIDS Society USA panel [J].
Carpenter, CCJ ;
Fischl, MA ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schooley, RT ;
Thompson, MA ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (01) :78-86
[14]   Adverse effects of antiretroviral therapy [J].
Carr, A ;
Cooper, DA .
LANCET, 2000, 356 (9239) :1423-1430
[15]   The effect of multiple doses of ritonavir on the pharmacokinetics of rifabutin [J].
Cato, A ;
Cavanaugh, J ;
Shi, H ;
Hsu, A ;
Leonard, J ;
Granneman, R .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (04) :414-421
[16]   9-(1,3-DIHYDROXY-2-PROPOXYMETHYL) GUANINE (GANCICLOVIR) IN THE TREATMENT OF CYTOMEGALOVIRUS GASTROINTESTINAL-DISEASE WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
CHACHOUA, A ;
DIETERICH, D ;
KRASINSKI, K ;
GREENE, J ;
LAUBENSTEIN, L ;
WERNZ, J ;
BUHLES, W ;
KORETZ, S .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (02) :133-137
[17]  
*CTR DIS CONTR PRE, 1999, HIV AIDS SURV REP, V11, P1
[18]   Effect of heating human sera at a temperature necessary to deactivate human immunodeficiency virus on measurement of free phenytoin, free valproic acid, and free carbamazepine concentrations [J].
Dasgupta, A ;
Wells, A ;
Chow, L .
THERAPEUTIC DRUG MONITORING, 1999, 21 (04) :421-425
[19]   EFFECT OF HEATING SERA UNDER CONDITIONS NECESSARY FOR DEACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS ON COMMONLY MONITORED THERAPEUTIC DRUGS [J].
DASGUPTA, A ;
BARD, D .
THERAPEUTIC DRUG MONITORING, 1994, 16 (06) :613-615
[20]  
DEEKS SG, 1997, JAMA-J AM MED ASSOC, V11, P1665